Glycomic 治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00029576
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 330
Buy Now

糖组治疗市场预计将从2021年的990.2146亿美元增长到2028年的2575.7879亿美元;预计 2022 年至 2028 年复合年增长率为 15.8%。

该报告重点介绍了推动市场增长的主要趋势和因素。糖组学专注于复杂碳水化合物的结构和功能,如糖蛋白、糖脂和糖胺聚糖中的结构和功能。聚糖是生物系统中大部分结构变异的原因,它们在细胞表面的表现通常称为“糖组”。这些聚糖存在于微生物组的许多区域,包括细胞表面和蛋白质,并且可能非常复杂。微生物糖组学有望彻底改变疾病诊断、癌症检测、个性化医疗、抗菌疫苗和药物发现。作为治疗剂,聚糖整合纳米材料可用作针对病毒和细菌感染以及癌细胞的疫苗。

该报告提供了对全球糖组治疗市场的见解和深入分析,强调了各种参数,包括市场趋势、技术进步、市场动态以及全球领先市场参与者的竞争格局分析。它还包括 COVID-19 大流行对所有地区市场的影响。 COVID-19 大流行对糖组治疗市场的总体影响好坏参半;因此,该市场仍然受到关注,预计未来几年将会增长。医疗保健系统负担过重,向所有患者提供医疗服务成为一项挑战。此外,生物科技行业也面临疫情的不利影响。在 COVID-19 大流行期间,医疗器械公司发现管理运营遇到困难。许多糖组疗法公司在美国开展业务,疫情严重影响了多家企业。然而,在疫情限制恢复正常后,手术量恢复到正常水平。随着 COVID-19 康复率的提高,医院逐渐恢复了择期手术。医学治疗和疫苗开发应用中对基于聚糖的药物的需求也有所增加。

战略见解

基于地理的见解

按地理位置划分,全球糖组治疗市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚、南美)韩国、以及亚太地区其他地区)、中东和美国非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

市场洞察

加强糖组学领域的研究和开发治疗

聚糖极其复杂,存在于微生物组成分的许多领域,例如蛋白质和细胞表面。研究人员和参与者积极参与糖组学行业,并不断关注技术发展,以提供传统技术的更好替代方案。研究和研究的一些例子下面提到了糖组治疗市场的发展:

  • 2022 年 2 月,美国国家科学基金会 (NSF) 向由弗吉尼亚理工大学联合领导的新的多所大学合作伙伴关系拨款约 2300 万美元和佐治亚大学,2020 年,加速美国的糖材料研究。此次合作汇聚了来自这些机构以及布兰迪斯大学、伦斯勒理工学院和北卡罗来纳大学教堂山分校的顶尖科学家和工程师,建立了国家糖材料研究中心。
  • 2022 年 3 月, Palleon Pharmaceuticals 是一家在乙二醇免疫学领域治疗癌症和炎症性疾病的先驱公司,宣布该公司 E-602 1/2 期研究中的第一位患者接受了治疗,该研究针对的是患有晚期癌症的患者。这项名为 GLIMMER-01(糖免疫调节)的研究是 Palleon 癌症免疫治疗新方法的第一项临床研究,该方法针对免疫抑制唾液聚糖。
  • 2022 年 4 月,CPTAC 糖蛋白组学研究人员开发了“ “肽优先”多属性聚糖识别方法。
  • 2022年3月,日本研究人员揭示了β-1,2-葡聚糖相关酶的精确机制,为复杂的糖代谢提供了新信息。来自新泻大学和东京理科大学的研究小组鉴定了一种具有糖基转移酶活性的新酶的结构和功能。这项调查的结果于2022年1月19日公布,并刊登在《生物化学杂志》第298卷第3期上。
  • 根据该大学研究人员于2022年2月发表的一项研究哥本哈根糖组学中心的研究表明,现在可以通过糖组学研究在不使用动物的情况下生产肝素。
  • 2022 年 2 月,由弗吉尼亚理工大学和佐治亚大学联合领导的专注于糖材料研究的国家研究中心 GlycoMIP ,在两所大学举行了剪彩仪式,庆祝其国家用户设施的盛大开业。 GlycoMIP 将通过突破性的研究和独特的国家用户设施来解决全国范围内糖材料合成、计算机建模、材料表征和知识共享方面的瓶颈,该设施将为科学界提供关键工具和服务。
< p>糖组学领域的此类进步显着推动了糖组治疗市场的增长。

基于类别的见解

根据类别,糖组治疗市场分为分离的和合成的。 2021年,合成细分市场占据了更大的市场份额。然而,预计孤立细分市场在预测期内的复合年增长率将达到 16.3%。  

Glycomic 治疗市场,按类别划分 – 2021年和2028年

基于结构的见解

根据结构,糖组治疗市场分为糖蛋白、靶向唾液酸、蛋白多糖、靶向糖胺聚糖、糖磷脂酰肌醇 (GPI) 锚定蛋白质和基于肝素的聚糖,针对糖鞘脂等。糖蛋白细分市场在 2021 年占据最大的市场份额。然而,靶向唾液酸细分市场预计在预测期内复合年增长率最高。

基于适应症的见解

基于据指示,糖组治疗市场分为血栓形成和血栓形成。化学预防、贫血、抗粘连和抗炎、白内障、戈谢病、MPS-1 和IV、癌症、阿尔茨海默病、甲型流感和流感乙等。 A 型和 A 型流感B 细分市场在 2021 年占据最大的市场份额,预计在预测期内将继续保持类似的趋势。

基于行动模式的洞察

基于行动模式,糖组治疗市场分为抑制神经氨酸酶;抑制乙酰肝素酶和选择素,并阻断生长因子和硫酸乙酰肝素之间的相互作用;促红细胞生成素酶替代疗法(ERT);组织纤溶酶原激活剂;抑制葡萄糖神经酰胺合酶;白细胞介素1, 2 & 3;贝塔& γ干扰素;和别的。 2021年,促红细胞生成素和酶替代疗法(ERT)细分市场占据最大份额。然而,抑制神经氨酸酶领域预计在预测期内复合年增长率最高。

Intellihep Ltd; Protalix 生物治疗; BioMarin 制药公司; Genzyme 公司(赛诺菲); Halozyme 治疗公司;拜耳公司;阿尔泽恩公司;糖玛尔;葛兰素史克公司;和 F. Hoffmann-La Roche Ltd 是糖组治疗市场的领先企业之一。这些公司一直在实施各种有助于其发展的战略,从而在市场上取得了一些发展。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment led the glycomic therapeutics market?

The synthetic segment under class segment held the largest market share in 2021.

Who are the key players in the glycomic therapeutics market?

The glycomic therapeutics market majorly consists of the players such as Intellihep Ltd; Protalix Biotherapeutics; BioMarin Pharmaceutical Inc.; Genzyme Corporation (Sanofi); Halozyme Therapeutics, Inc.; Bayer AG; Alzheon, Inc.; GlycoMar; GlaxoSmithKline plc.; and F. Hoffmann-La Roche Ltd.

Which region is fastest growing?

Based on geography, the APAC region is anticipated to witness the highest CAGR in glycomic therapeutics market during the forecast period.

What are the drivers and opportunities for the glycomic therapeutics market?

The growth of the market is attributed to wide application in various disorders followed by the development of new treatment processes, increasing research and development in the field of glycomic therapeutics, and expanding R&D investments and rising use of glycomics in various diseases leading to development of new treatment processes.

The List of Companies - Glycomic Therapeutics Market

  1. Intellihep Ltd
  2. Protalix Biotherapeutics
  3. BioMarin Pharmaceutical Inc.
  4. Genzyme Corporation (Sanofi)  
  5. Halozyme Therapeutics, Inc.       
  6. Bayer AG            
  7. Alzheon, Inc.     
  8. GlycoMar
  9. GlaxoSmithKline plc.      
  10. F. Hoffmann-La Roche Ltd 

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports